Ponoi Management, LLC
- SEC CIK
- 0001720702
- Latest filing
- Nov 14, 2022
NGM holding history
NGM Biopharmaceuticals Inc in every 13F filed by Ponoi Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NGM overviewAll 13F holders of NGMFull Q3 2022 holdings
- Shares (Q3 2022)
- 1,298,908
- Value
- $17.0M
- % of portfolio
- 23.2%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 1,298,908 | $17.0M | 23.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,298,908 | $16.7M | 26.3% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,298,908 | $19.8M | 25.7% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,298,908 | $23.0M | 21.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,298,908 | $27.3M | 24.2% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,298,908 | $25.6M | 14.2% | 00.0% | Unchanged | Holders |
| Q1 2021 | 1,298,908 | $37.8M | 22.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.